2026-525256-29-00
已完成
1 期
Randomized, open-label, laboratory-blinded, balanced, single dose, 3-treatment, 6-sequence, 3-period crossover comparative bioavailability study comparing Finerenone, 20 mg, film-coated tablets (Prototype 1, Prototype 2) and Kerendia, 20 mg, film-coated tablets under fasting conditions in healthy participants.
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年3月9日最近更新:
概览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
- 入组人数
- 36
- 试验地点
- 2
概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical R&D
Scientific
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
研究点 (2)
Loading locations...
相似试验
尚未招募
1 期
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative bioavailability of Test Product Naproxen sodium 660 mg modified release tablets to Reference Product Actromadol 660 mg Modified-Release tablets in healthy adult male and female subjects under fed conditions.2025-521732-11-00Laboratorios Cinfa S.A.32
已完成
1 期
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 12 mg film-coated tablets versus reference product Fycompa 12 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.2023-503345-59-00Laboratorios Cinfa S.A.36
尚未招募
1 期
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative bioavailability of Test Product Naproxen sodium 660 mg modified release tablets to Reference Product Actromadol 660 mg Modified-Release tablets in healthy adult male and female subjects under fasting conditions.s.2025-524035-39-00Laboratorios Cinfa S.A.32
已完成
1 期
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 2 mg film-coated tablets versus reference product Fycompa 2 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.2023-504132-18-00Laboratorios Cinfa S.A.36
招募中
4 期
ACLR with suspensory and interference fixationCTRI/2025/01/079716Dr. Rudra Prasad M S80